These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26995965)

  • 1. [TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].
    Daks AA; Petukhov AV; Shuvalov OY; Vasilieva EA; Melino G; Barlev NA; Fedorova OA
    Tsitologiia; 2015; 57(12):876-9. PubMed ID: 26995965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.
    Wu H; Zeinab RA; Flores ER; Leng RP
    Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
    Jung YS; Qian Y; Chen X
    J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
    Yan W; Chen X; Zhang Y; Zhang J; Jung YS; Chen X
    J Biol Chem; 2013 Feb; 288(5):2907-13. PubMed ID: 23271742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itch/AIP4 associates with and promotes p63 protein degradation.
    Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
    Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.
    Jung YS; Qian Y; Yan W; Chen X
    J Invest Dermatol; 2013 May; 133(5):1178-87. PubMed ID: 23235527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades.
    Min B; Ryu J; Chi SW; Yi GS
    Biochem Biophys Res Commun; 2015 Nov; 467(2):316-21. PubMed ID: 26435500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
    Zheng G; Ning J; Yang YC
    Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
    Yan W; Jung YS; Zhang Y; Chen X
    PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.
    Bergiers I; Bridoux L; Nguyen N; Twizere JC; Rezsöhazy R
    PLoS One; 2013; 8(11):e80387. PubMed ID: 24244684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of p63 by Itch.
    Melino G; Knight RA; Cesareni G
    Cell Cycle; 2006 Aug; 5(16):1735-9. PubMed ID: 16931910
    [No Abstract]   [Full Text] [Related]  

  • 16. Pirh2, an E3 ligase, regulates the AIP4-p73 regulatory pathway by modulating AIP4 expression and ubiquitination.
    Abou Zeinab R; Wu HH; Abuetabh Y; Leng S; Sergi C; Eisenstat DD; Leng RP
    Carcinogenesis; 2021 Apr; 42(4):650-662. PubMed ID: 33569599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin-protein ligase Itch regulates p73 stability.
    Rossi M; De Laurenzi V; Munarriz E; Green DR; Liu YC; Vousden KH; Cesareni G; Melino G
    EMBO J; 2005 Feb; 24(4):836-48. PubMed ID: 15678106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
    Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
    Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.